Roche Holding AG (RHHBY)
30.35
-0.60
(-1.94%)
USD |
OTCM |
May 13, 16:03
Roche Net Income (Semi Annual): 4.921B for Dec. 31, 2023
Net Income (Semi Annual) Chart
Historical Net Income (Semi Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.921B |
| June 30, 2023 | 7.941B |
| December 31, 2022 | 4.044B |
| June 30, 2022 | 8.839B |
| December 31, 2021 | 6.647B |
| June 30, 2021 | 8.568B |
| December 31, 2020 | 6.878B |
| June 30, 2020 | 8.383B |
| December 31, 2019 | 4.928B |
| June 30, 2019 | 8.595B |
| December 31, 2018 | 3.204B |
| June 30, 2018 | 7.420B |
| December 31, 2017 | 3.196B |
| June 30, 2017 | 5.559B |
| December 31, 2016 | 4.195B |
| June 30, 2016 | 5.538B |
| December 31, 2015 | 3.742B |
| June 30, 2015 | 5.469B |
| Date | Value |
|---|---|
| December 31, 2014 | 3.939B |
| June 30, 2014 | 6.223B |
| December 31, 2013 | 5.782B |
| June 30, 2013 | 6.303B |
| December 31, 2012 | 5.614B |
| June 30, 2012 | 4.487B |
| December 31, 2011 | 4.593B |
| June 30, 2011 | 5.928B |
| December 31, 2010 | 3.282B |
| June 30, 2010 | 4.935B |
| December 31, 2009 | 4.220B |
| June 30, 2009 | 3.128B |
| December 31, 2008 | 3.589B |
| June 30, 2008 | 4.675B |
| December 31, 2007 | 4.227B |
| June 30, 2007 | 4.024B |
| December 31, 2006 | 3.167B |
| June 30, 2006 | 3.196B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Semi Annual) Range, Past 5 Years
4.044B
Minimum
Dec 2022
8.839B
Maximum
Jun 2022
6.974B
Average
7.409B
Median
Net Income (Semi Annual) Benchmarks
| Novartis AG | -- |
| Pfizer Inc | -- |
| Eli Lilly and Co | -- |
| ADC Therapeutics SA | -- |
| AstraZeneca PLC | -- |